AMGN Rachna Khosla sells $435K worth of shares
Jun 07, 2025, 4:32 AM
0.00%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
Rachna Khosla sold 1,500 shares of AMGN on 5 June at $289.68 per share, worth a total of $435K. They now own 8,162 AMGN shares, or a 16% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.